About the position
The Hybrid Technology Hub Centre of Excellence at Oslo University Hospital and the University of Oslo Norway ( inviting applications for a threeyear PhD position.
The recruited candidate will take part in an international TRANSCAN3 research project that aims to advance personalized cancer therapies by integrating vascular and immune components into a tumoronchip model. TRANSCAN3 is an ERANET (European Research Area network) initiative that coordinates national and regional cancer research programmes across Europe to support translational cancer research ().
The successful applicant will work under the supervision of Professor Stefan Krauss and will be embedded in an interdisciplinary team collaborating closely with researchers at the CeMM Research Center for Molecular Medicine and the University of Tübingen.
Oslo University Hospital is a workplace with great diversity. We believe this is absolutely crucial to solving the tasks required of us. We therefore want this diversity to be reflected among the applicants for our positions and encourage everyone to apply regardless of who you are and what background you have.
Oslo University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions and we encourage all qualified candidates regardless of background to apply!
Key information
Application deadline:
11.01.2026
Employer:
Oslo universitetssykehus HF
Full-time/part-time:
Full-time
Employment type:
Contract
Percentage of full-time:
100
Key tasks
The PhD will focus on to develop a robust organonchip microfluidic platform for indepth analysis of immune cell and tumor endothelial cell behavior in the tumor microenvironment and their treatment responses.
Qualifications
- Masters degree in Biology or Biotechnology.
- Minimum of 2 years of relevant post-graduation hands-on laboratory experience.
- Proven experience in advanced mammalian cell culture including 3D models.
- Demonstrated expertise with advanced in vitro models including organ-on-chip systems.
- Experience with vascularization models.
- Proficiency in standard molecular biology techniques including RT-qPCR ELISA immunocytochemistry and flow cytometry.
- Experience in sample preparation for imaging including cryosectioning and immunofluorescence staining.
- Hands-on experience with advanced microscopy techniques.
- Strong skills in image analysis software and methodologies.
- Excellent written verbal and presentation skills in English.
The application must include
- A motivation letter.
- CV (summarizing education positions and academic work).
- A recommendation letter from the previous relevant work.
- Documents certificates contracts confirming education and relevant working experience.
Personal qualities
- Teamwork skills and positive working culture.
- Ability to work in a highly competitive research environment.
- Flexibility and problem-solving skills.
- Result-oriented.
- Ability to deliver in time and within budgets.
- Ability to independently design carry out and interpret experiments.
- Ability to critically design and write manuscripts based on the obtained research results.
We offer
- A positive and stimulating working environment.
- Salary according to agreement.
- Competitive conditions.
- Possibility of extension.
Address: Sognsvannsveien 9 0372 Oslo Norway
Contacts
Professor Stefan Krauss
Centre Leader Hybrid Technology Hub
Email:
Petter Angell Olsen
Administrative Coordinator
Email:
About the employer
Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavias largest hospital we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of national and multi-regional assignments and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals and is a significant role player within the education of a large variety of health care personnel.
About the positionThe Hybrid Technology Hub Centre of Excellence at Oslo University Hospital and the University of Oslo Norway ( inviting applications for a threeyear PhD position.The recruited candidate will take part in an international TRANSCAN3 research project that aims to advance personalized ...
About the position
The Hybrid Technology Hub Centre of Excellence at Oslo University Hospital and the University of Oslo Norway ( inviting applications for a threeyear PhD position.
The recruited candidate will take part in an international TRANSCAN3 research project that aims to advance personalized cancer therapies by integrating vascular and immune components into a tumoronchip model. TRANSCAN3 is an ERANET (European Research Area network) initiative that coordinates national and regional cancer research programmes across Europe to support translational cancer research ().
The successful applicant will work under the supervision of Professor Stefan Krauss and will be embedded in an interdisciplinary team collaborating closely with researchers at the CeMM Research Center for Molecular Medicine and the University of Tübingen.
Oslo University Hospital is a workplace with great diversity. We believe this is absolutely crucial to solving the tasks required of us. We therefore want this diversity to be reflected among the applicants for our positions and encourage everyone to apply regardless of who you are and what background you have.
Oslo University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions and we encourage all qualified candidates regardless of background to apply!
Key information
Application deadline:
11.01.2026
Employer:
Oslo universitetssykehus HF
Full-time/part-time:
Full-time
Employment type:
Contract
Percentage of full-time:
100
Key tasks
The PhD will focus on to develop a robust organonchip microfluidic platform for indepth analysis of immune cell and tumor endothelial cell behavior in the tumor microenvironment and their treatment responses.
Qualifications
- Masters degree in Biology or Biotechnology.
- Minimum of 2 years of relevant post-graduation hands-on laboratory experience.
- Proven experience in advanced mammalian cell culture including 3D models.
- Demonstrated expertise with advanced in vitro models including organ-on-chip systems.
- Experience with vascularization models.
- Proficiency in standard molecular biology techniques including RT-qPCR ELISA immunocytochemistry and flow cytometry.
- Experience in sample preparation for imaging including cryosectioning and immunofluorescence staining.
- Hands-on experience with advanced microscopy techniques.
- Strong skills in image analysis software and methodologies.
- Excellent written verbal and presentation skills in English.
The application must include
- A motivation letter.
- CV (summarizing education positions and academic work).
- A recommendation letter from the previous relevant work.
- Documents certificates contracts confirming education and relevant working experience.
Personal qualities
- Teamwork skills and positive working culture.
- Ability to work in a highly competitive research environment.
- Flexibility and problem-solving skills.
- Result-oriented.
- Ability to deliver in time and within budgets.
- Ability to independently design carry out and interpret experiments.
- Ability to critically design and write manuscripts based on the obtained research results.
We offer
- A positive and stimulating working environment.
- Salary according to agreement.
- Competitive conditions.
- Possibility of extension.
Address: Sognsvannsveien 9 0372 Oslo Norway
Contacts
Professor Stefan Krauss
Centre Leader Hybrid Technology Hub
Email:
Petter Angell Olsen
Administrative Coordinator
Email:
About the employer
Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavias largest hospital we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of national and multi-regional assignments and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals and is a significant role player within the education of a large variety of health care personnel.
View more
View less
Job Location:
Monthly Salary:
Posted on:
Vacancies:
